172 related articles for article (PubMed ID: 7486915)
21. Sulfa use, dihydropteroate synthase mutations, and Pneumocystis jirovecii pneumonia.
Stein CR; Poole C; Kazanjian P; Meshnick SR
Emerg Infect Dis; 2004 Oct; 10(10):1760-5. PubMed ID: 15504261
[TBL] [Abstract][Full Text] [Related]
22. Monodrug efficacies of sulfonamides in prophylaxis for Pneumocystis carinii pneumonia.
Hughes WT; Killmar J
Antimicrob Agents Chemother; 1996 Apr; 40(4):962-5. PubMed ID: 8849260
[TBL] [Abstract][Full Text] [Related]
23. Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P carinii pneumonia in patients with HIV-1: a prospective study.
Navin TR; Beard CB; Huang L; del Rio C; Lee S; Pieniazek NJ; Carter JL; Le T; Hightower A; Rimland D
Lancet; 2001 Aug; 358(9281):545-9. PubMed ID: 11520525
[TBL] [Abstract][Full Text] [Related]
24. Mutations in the dihydropteroate synthase gene of human-derived Pneumocystis carinii isolates from Italy are infrequent but correlate with prior sulfa prophylaxis.
Ma L; Kovacs JA; Cargnel A; Valerio A; Fantoni G; Atzori C
J Infect Dis; 2002 May; 185(10):1530-2. PubMed ID: 11992293
[TBL] [Abstract][Full Text] [Related]
25. Dihydropteroate synthase gene mutations in Pneumocystis and sulfa resistance.
Huang L; Crothers K; Atzori C; Benfield T; Miller R; Rabodonirina M; Helweg-Larsen J
Emerg Infect Dis; 2004 Oct; 10(10):1721-8. PubMed ID: 15504256
[TBL] [Abstract][Full Text] [Related]
26. Dihydropteroate synthase polymorphisms in Pneumocystis carinii.
Lane BR; Ast JC; Hossler PA; Mindell DP; Bartlett MS; Smith JW; Meshnick SR
J Infect Dis; 1997 Feb; 175(2):482-5. PubMed ID: 9203679
[TBL] [Abstract][Full Text] [Related]
27. Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia.
Helweg-Larsen J; Benfield TL; Eugen-Olsen J; Lundgren JD; Lundgren B
Lancet; 1999 Oct; 354(9187):1347-51. PubMed ID: 10533864
[TBL] [Abstract][Full Text] [Related]
28. Detection of Pneumocystis carinii and characterization of mutations associated with sulfa resistance in bronchoalveolar lavage samples from human immunodeficiency virus-infected subjects.
Zingale A; Carrera P; Lazzarin A; Scarpellini P
J Clin Microbiol; 2003 Jun; 41(6):2709-12. PubMed ID: 12791912
[TBL] [Abstract][Full Text] [Related]
29. Structure-activity of sulfones and sulfonamides on dihydropteroate synthetase from Neisseria meingitidis.
Ho RI; Corman L; Mores SA; Schneider H
Antimicrob Agents Chemother; 1975 Jun; 7(6):758-63. PubMed ID: 808157
[TBL] [Abstract][Full Text] [Related]
30. Failure of co-trimoxazole in Pneumocystis carinii infection and mutations in dihydropteroate synthase gene.
Mei Q; Gurunathan S; Masur H; Kovacs JA
Lancet; 1998 May; 351(9116):1631-2. PubMed ID: 9620722
[No Abstract] [Full Text] [Related]
31. Inhibition studies of sulfonamide-containing folate analogs in yeast.
Patel O; Satchell J; Baell J; Fernley R; Coloe P; Macreadie I
Microb Drug Resist; 2003; 9(2):139-46. PubMed ID: 12820798
[TBL] [Abstract][Full Text] [Related]
32. High Prevalence of Pneumocystis jirovecii Dihydropteroate Synthase Gene Mutations in Patients with a First Episode of Pneumocystis Pneumonia in Santiago, Chile, and Clinical Response to Trimethoprim-Sulfamethoxazole Therapy.
Ponce CA; Chabé M; George C; Cárdenas A; Durán L; Guerrero J; Bustamante R; Matos O; Huang L; Miller RF; Vargas SL
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855071
[TBL] [Abstract][Full Text] [Related]
33. Characterization of de novo folate synthesis in Pneumocystis carinii and Toxoplasma gondii: potential for screening therapeutic agents.
Kovacs JA; Allegra CJ; Beaver J; Boarman D; Lewis M; Parrillo JE; Chabner B; Masur H
J Infect Dis; 1989 Aug; 160(2):312-20. PubMed ID: 2527275
[TBL] [Abstract][Full Text] [Related]
34. The multifunctional folic acid synthesis fas gene of Pneumocystis carinii appears to encode dihydropteroate synthase and hydroxymethyldihydropterin pyrophosphokinase.
Volpe F; Dyer M; Scaife JG; Darby G; Stammers DK; Delves CJ
Gene; 1992 Mar; 112(2):213-8. PubMed ID: 1313386
[TBL] [Abstract][Full Text] [Related]
35. Genetic divergence of the dihydrofolate reductase and dihydropteroate synthase genes in Pneumocystis carinii from 7 different host species.
Ma L; Imamichi H; Sukura A; Kovacs JA
J Infect Dis; 2001 Nov; 184(10):1358-62. PubMed ID: 11679931
[TBL] [Abstract][Full Text] [Related]
36. Mutations in dihydropteroate synthase gene of Pneumocystis carinii in HIV patients with Pneumocystis carinii pneumonia.
Visconti E; Ortona E; Mencarini P; Margutti P; Marinaci S; Zolfo M; Siracusano A; Tamburrini E
Int J Antimicrob Agents; 2001 Dec; 18(6):547-51. PubMed ID: 11738342
[TBL] [Abstract][Full Text] [Related]
37. Contribution of dihydropteroate synthase gene typing for Pneumocystis carinii f.sp. hominis epidemiology.
Santos LD; Lacube P; Latouche S; Kac G; Mayaud C; Marteau M; Poirot JL; Maury E; Guillot J; Roux P
J Eukaryot Microbiol; 1999; 46(5):133S-134S. PubMed ID: 10519287
[No Abstract] [Full Text] [Related]
38. PCR-RFLP analysis of the DHPS gene for the study of resistance of Pneumocystis carinii to sulpha drugs in patients with co-infection PCP/HIV.
Costa MC; Helweg-Larsen J; Antunes F; Lungren B; Diogo J; Matos O
J Eukaryot Microbiol; 2001; Suppl():148S-149S. PubMed ID: 11906035
[No Abstract] [Full Text] [Related]
39. Promoter strength of folic acid synthesis genes affects sulfa drug resistance in Saccharomyces cerevisiae.
Iliades P; Berglez J; Meshnick S; Macreadie I
Microb Drug Resist; 2003; 9(3):249-55. PubMed ID: 12959403
[TBL] [Abstract][Full Text] [Related]
40. A rapid assay for dihydropteroate synthase activity suitable for identification of inhibitors.
Fernley RT; Iliades P; Macreadie I
Anal Biochem; 2007 Jan; 360(2):227-34. PubMed ID: 17134675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
